
Continuum Health Ventures (CHV) is an early-stage venture capital fund that seeds, nurtures and accelerates the next generation of Healthtech, Techbio and Healthspan Extension (Longevity) startups that will focus on disrupting sickcare.

The 'Continuum' Approach
Prevention and Aging Biology: We are a thesis-driven organization focused on the convergence of health and technology within the Fifth Industrial Revolution. We believe we are in the early innings of digitizing healthcare, and our mission is to leverage precision and personalized interventions to identify disease, before it's a material issue. We also are focused on stagnating and/or reversing some of the disease hallmarks associated with aging.
Thesis


Partnering for the Future: We are on a journey to identify the next generation of founders and startups poised to define the future of medicine. As former doctors, scientists, techonologists, and founders ourselves, we understand the road ahead and immerse ourselves deeply with the teams we back. Our goal is to be active, early investors—committed partners who remain by your side all the way to the finish line.
Identify.
Driving Growth Beyond Capital: We provide the essential capital, active operational support, and unparalleled market access your venture needs. While our primary focus is the US, our reach extends globally to Canada, the EU, the Middle East, India, Japan, Korea, Singapore, and beyond. We combine strategic thinking with a powerful network across payors, providers, pharma, device, and consumer tech to ensure your commercialization is expedited and highly effective.
Catalyze.


Continuum in Numbers
247
Employees
5
Core Teams
Identity
326
Partners Worldwide
$200m
Capital

At Continuum Health Ventures, we are committed to finding and supporting the most innovative ideas. Our team of experts brings a wealth of experience and specialized skills to the table, allowing us to make informed choices that have the potential to transform healthcare.













